What is Tarsus Pharmaceuticals, Inc.'s AOCI?

Tarsus Pharmaceuticals, Inc. (TARS) reported AOCI of -$298K in Q1 2026.

How has Tarsus Pharmaceuticals, Inc.'s AOCI changed year-over-year?

Tarsus Pharmaceuticals, Inc.'s AOCI decreased by 450.6% year-over-year, from $85K to -$298K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Tarsus Pharmaceuticals, Inc. TARS AOCI

AOCI at other companies

AbbVieABBV

-$1.15B+33.8%

Bausch + LombBLCO

-$1.2B+8.1%

Regeneron PharmaceuticalsREGN

$11.9M-59.1%

Warby ParkerWRBY

-$1.81M+6.4%

GlaukosGKOS

$2.64M+1.5%

Other financials

Income statement

See full

Revenue$162.1M+107%

Gross profit$152.7M+109%

Operating income-$6.1M+76.7%

Net income-$7.0M+72.3%

EPS (diluted)-$0.16+75.0%

Balance sheet

See full

Cash & equivalents$104.2M-41.6%

Total debt$88.7M+22.5%

Total equity$349.0M+1.9%

Total assets$581.1M+16.1%

Cash flow

See full

Operating cash flow-$24.7M-19.4%

CapEx$5.8M+886%

Free cash flow-$30.5M-43.4%

Valuation

See full

Market cap$2.85B+41.1%

Enterprise value$2.83B+47.8%

P/S5.3×-3.3×

Profitability

See full

Gross margin42.7%—

Operating margin-9.5%-4.2pp

Net margin-9%-4.0pp

FCF margin-28%-12.6pp

Returns & leverage

See full

Return on equity-14%-5.2pp

Debt / equity0.3×0.0×

Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s AOCI?: Tarsus Pharmaceuticals, Inc. (TARS) reported AOCI of -$298K in Q1 2026.
How has Tarsus Pharmaceuticals, Inc.'s AOCI changed year-over-year?: Tarsus Pharmaceuticals, Inc.'s AOCI decreased by 450.6% year-over-year, from $85K to -$298K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.